Review-State-Aware Comparison
Andrographis vs Arctic Seaberry
An automated side-by-side view of two public profiles. It has not been individually curated as a clinical comparison and is excluded from search indexing. Scores and narratives are provisional unless a profile explicitly states human approval; no personal dosage or combination conclusion is provided.
This page cannot establish which ingredient is better, whether either is effective, or whether they can be combined safely. Editorial and quality-gate review approved this evidence record. Editorial and quality-gate review approved this evidence record.
Human-Reviewed Benefit Text
Andrographis
Arctic Seaberry
Human-Reviewed Mechanism Text
Andrographolide and related compounds inhibit NF-κB transcriptional activity with IC₅₀ values of 2-2.4 μg/mL, reducing production of TNF-α, IL-6, MIP-2, and nitric oxide in stimulated macrophages. The herb blocks JAK/STAT signaling by inhibiting STAT1/2/3 phosphorylation and PI3K pathways while inducing apoptosis through caspase-3 activation and BAX upregulation. Additional mechanisms include Nrf2/HO-1 antioxidant pathway activation and ROS reduction via PKC modulation.
Isorhamnetin and quercetin modulate PI3K/AKT/mTOR, NF-κB, MAPK, and Wnt/β-catenin pathways to promote apoptosis via Bax upregulation and Bcl-2/Bax ratio changes. Sea buckthorn polysaccharides activate Nrf2/HO-1/SOD-2 pathways for antioxidant effects. Flavonoids (6.25–100 μM) upregulate PPAR-γ/α, ABCA1, and CPT1A to enhance cholesterol efflux and fatty acid oxidation while inhibiting SREBP-2/LDLR for improved lipid metabolism.
Human-Reviewed Safety Text
Current research lacks comprehensive safety data, drug interaction profiles, and specific contraindications for andrographis supplementation. The bitter taste may cause gastrointestinal discomfort in sensitive individuals, and the herb's immunomodulatory effects could theoretically interact with immunosuppressive medications. Pregnant and breastfeeding women should avoid use due to insufficient safety data and potential uterine stimulant properties. Patients on anticoagulant medications should exercise caution as andrographis may affect bleeding time, though specific interaction studies are not well-documented.
Current research reports no adverse effects in animal models at tested doses up to 50 mg/kg, though comprehensive human safety data is limited. No specific drug interactions or contraindications have been identified in available studies, but this may reflect insufficient clinical investigation rather than confirmed safety. Pregnant and breastfeeding women should exercise caution due to lack of safety data in these populations. Individuals taking anticoagulant medications should consult healthcare providers, as high vitamin C content may theoretically affect blood clotting parameters.
Comparison summary
This automated view does not establish that either Andrographis or Arctic Seaberry is effective, superior, suitable, or safe to combine. Both have the same provisional public score (10/10). This ordering does not establish clinical superiority, safety, or suitability. Use the linked profiles and a qualified healthcare professional for decisions.
Frequently Asked Questions
Is Andrographis or Arctic Seaberry better?
Andrographis and Arctic Seaberry have the same provisional public score (10/10). A score tie does not establish equivalent evidence or outcomes.
Can you take Andrographis and Arctic Seaberry together?
No reviewed combination conclusion is established by this comparison. A missing reviewed interaction record means unknown, not safe. Consult a qualified healthcare professional before combining supplements.
What is the main difference between Andrographis and Arctic Seaberry?
Andrographis is categorized as herb (botanical), while Arctic Seaberry is categorized as berry (Compound). Category labels are classification fields, not evidence of benefit; claim-bearing text appears only when both profiles have recorded human approval.


